MedPath

Prediction for glycemic variability in patients treated with insulin glargine 300 U/ml on basal insulin therapy

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000039437
Lead Sponsor
Inuyama Chuo General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

judged to be unsuitable for participation for medical reasons

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A time and a cutoff value which can the most exactly predict TIR(70 to 180 mg/dL) < 70 percent
Secondary Outcome Measures
NameTimeMethod
Times which the most correlate to CV or TBR(< 70 mg/dL) Times and cutoff values which can the most exactly predict CV > 36 percent or TBR(< 70 mg/dL)< 4 percent Times during daytime where differences between two glucose levels the most correlate to CV or TBR(< 70 mg/dL) Times during daytime where differences between two glucose levels can the most exactly predict CV > 36 percent or TBR(< 70 mg/dL)< 4 percent and those cutoff values
© Copyright 2025. All Rights Reserved by MedPath